Estrogen Receptor Activation and Cardioprotection in Ischemia Reperfusion Injury

Trends in Cardiovascular Medicine

Volumn 20, Issue 3, 2010, Pages 73-78

  Deschamps, Anne M ^a   Murphy, Elizabeth ^a   Sun, Junhui ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE;

CARDIOVASCULAR FUNCTION; FEMALE; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; KNOCKOUT MOUSE; NITROSYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CARDIOVASCULAR AGENTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 78649870094     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.05.001     Document Type: Review

References (40)

1. Anderson G., Limacher M., Assaf A., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291:1701-1712.
2. Babiker F.A., Lips D.J., Delvaux E., et al. Oestrogen modulates cardiac ischaemic remodelling through oestrogen receptor-specific mechanisms. Acta Physiol (Oxf) 2007, 189:23-31.
3. Booth E.A., Lucchesi B.R. Estrogen-mediated protection in myocardial ischemia-reperfusion injury. Cardiovasc Toxicol 2008, 8:101-113.
4. Booth E.A., Marchesi M., Kilbourne E., et al. 17β-Estradiol as a receptor-mediated cardioprotective agent. J Pharmacol Exp Ther 2003, 307:395-401.
5. Booth E.A., Obeid N.R., Lucchesi B.R. Activation of estrogen receptor-α protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol 2005, 289:H2039-H2047.
6. Bopassa J.C., Eghbali M., Toro L., et al. A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol 2010, 298:H16-H23.
7. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., et al. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999, 103:401-406.
8. Chung T.H., Wang S.M., Liang J.Y., et al. The interaction of estrogen receptor α and caveolin-3 regulates connexin43 phosphorylation in metabolic inhibition-treated rat cardiomyocytes. Int J Biochem Cell Biol 2009, 41:2323-2333.
9. Deschamps A.M., Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol 2009, 297:H1806-H1813.
10. Filardo E.J., Quinn J.A., Bland K.I., et al. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-1660.
11. Filice E., Recchia A.G., Pellegrino D., et al. A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat. J Physiol Pharmacol 2009, 60:3-10.
12. Gabel S.A., Walker V.R., London R.E., et al. Estrogen receptor α mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol 2005, 38:289-297.
13. Grohé C., Kahlert S., Löbbert K., et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 1997, 416:107-112.
14. Hale S., Birnbaum Y., Kloner R. Estradiol, administrated acutely, protects ischemic myocardium in both female and male rabbits. J Cardiovasc Pharmacol Ther 1997, 2:47-52.
15. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998, 280:605-613.
16. Jeanes H.L., Tabor C., Black D., et al. Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)α agonist and unaffected by an ERα antagonist. J Endocrinol 2008, 197:493-501.
17. Lin J., Steenbergen C., Murphy E., et al. Estrogen receptor-β activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation 2009, 120:245-254.
18. Lindsey S.H., Cohen J.A., Brosnihan K.B., et al. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 2009, 150:3753-3758.
19. Lizotte E., Grandy S.A., Tremblay A., et al. Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cell Physiol Biochem 2009, 23:75-86.
20. Martensson U.E.A., Salehi S.A., Windahl S., et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 2009, 150:687-698.
21. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ERα and ER β. Mol Interv 2003, 3:281-292.
22. Murphy E., Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res 2007, 75:478-486.
23. Nikolic I., Liu D., Bell J.A., et al. Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol 2007, 42:769-780.
24. Novotny J.L., Simpson A.M., Tomicek N.J., et al. Rapid estrogen receptor-α activation improves ischemic tolerance in aged female rats through a novel protein kinase Cε-dependent mechanism. Endocrinology 2009, 150:889-896.
25. Nuedling S., Karas R.H., Mendelsohn M.E., et al. Activation of estrogen receptor β is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett 2001, 502:103-108.
26. Patten R., Pourati I., Aronovitz M., et al. 17Estradiol reduces cardiomyocyte apoptosis-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 2004, 95:692-699.
27. Prossnitz E.R., Arterburn J.B., Smith H.O., et al. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008, 70:165-190.
28. Revankar C.M., Cimino D.F., Sklar L.A., et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
29. Ropero A.B., Eghbali M., Minosyan T.Y., et al. Heart estrogen receptor alpha: distinct membrane and nuclear distribution patterns and regulation by estrogen. J Mol Cell Cardiol 2006, 41:496-510.
30. Simoncini T., Hafezi-Moghadam A., Brazil D.P., et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000, 407:538-541.
31. Sun J., Morgan M., Shen R.F., et al. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res 2007, 101:1155-1163.
32. Sun J., Murphy E. Protein S-nitrosylation and cardioprotection. Circ Res 2010, 106:285-296.
33. Sun J., Picht E., Ginsburg K.S., et al. Hypercontractile female hearts exhibit increased S-nitrosylation of the l-type Ca2+ channel α1 subunit and reduced ischemia/reperfusion injury. Circ Res 2006, 98:403-411.
34. Terrell A.M., Crisostomo P.R., Markel T.A., et al. Postischemic infusion of 17-β-estradiol protects myocardial function and viability. J Surg Res 2008, 146:218-224.
35. Vitale C., Mendelsohn M.E., Rosano G.M.C. Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 2009, 6:532-542.
36. Vornehm N.D., Wang M., Abarbanell A., et al. Acute postischemic treatment with estrogen receptor-α agonist or estrogen receptor-β agonist improves myocardial recovery. Surgery 2009, 146:145-154.
37. Wang M., Crisostomo P.R., Markel T., et al. Estrogen receptor β mediates acute myocardial protection following ischemia. Surgery 2008, 144:233-238.
38. Wang M., Crisostomo P.R., Wairiuko G.M., et al. Estrogen receptor-β mediates acute myocardial protection in females. Am J Physiol 2006, 290:H2204-H2209.
39. Wang M., Wang Y., Weil B., et al. Estrogen receptor β mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol 2009, 296:R972-R978.
40. Yang S.H., Liu R., Perez E.J., et al. Mitochondrial localization of estrogen receptor β. Proc Natl Acad Sci U S A 2004, 101:4130-4135.